Funds · KROS

Who owns KROS?

Institutional ownership of Keros Therapeutics Inc. from Form 13F, Q2 2026

132 institutional managers reported holding Keros Therapeutics Inc. (KROS) in Form 13F filings for Q2 2026, with 19,964,529 shares worth $214M. The largest reported holder was Nantahala Capital Management, LLC. Managers that filed both quarters added a net 1,377,909 shares (+7.4%). 15 opened new positions and 30 sold out.

Funds holding
132
Value held
$214M
New / sold out
15 / 30
Net shares, same filers
+7.4%

Holdings as of June 30, 2026, the end of Q2 2026. Managers have 45 days after a quarter ends to file Form 13F (by August 14, 2026 for Q2 2026), so positions may have changed since.

Largest holders of KROS

FundValueShare of 13F holdingsSharesMove
Nantahala Capital Management, LLC$30.2M14.1%2,820,838Added
BlackRock, Inc.$29.9M14.0%2,794,217Added
AQR Capital Management LLC$10.4M4.8%967,859Added
Vanguard Capital Management LLC$8.9M4.2%833,596Added
Orbimed Advisors LLC$8.1M3.8%759,155Unchanged
Federated Hermes, Inc.$7.5M3.5%700,427Added
Vanguard Portfolio Management LLC$7.0M3.3%652,635Trimmed
Mackenzie Financial Corp$6.7M3.1%628,438Added
Madison Avenue Partners, LP$6.7M3.1%626,583Unchanged
Qube Research & Technologies Ltd$6.5M3.0%608,837Trimmed
Jacobs Levy Equity Management, Inc$6.5M3.0%605,445Trimmed
State Street Corp$5.8M2.7%541,193Trimmed
Geode Capital Management, LLC$5.5M2.6%510,841Trimmed
Dimensional Fund Advisors LP$4.9M2.3%460,541Added
Citadel Advisors LLC$4.2M2.0%396,098Trimmed
Renaissance Technologies LLC$3.8M1.8%359,086Trimmed
D. E. Shaw & Co., Inc.$2.9M1.3%267,460Trimmed
Bridgeway Capital Management, LLC$2.8M1.3%265,017Added
Nuveen, LLC$2.7M1.2%247,756Trimmed
ADAR1 Capital Management, LLC$2.6M1.2%246,818Added
Two Sigma Investments, LP$2.6M1.2%246,649Trimmed
Arrowstreet Capital, Limited Partnership$2.5M1.2%233,175Trimmed
Millennium Management LLC$2.0M0.9%184,822Added
Goldman Sachs Group Inc$1.9M0.9%177,846Trimmed
Charles Schwab Investment Management Inc$1.7M0.8%158,712Trimmed

Share of 13F holdings is each fund's shares as a share of the 19,964,529 KROS shares all 13F filers reported, not of shares outstanding.

The change in shares since the quarter before, adjusted for stock splits and priced at the Q2 2026 value per share. Funds bought $44.0M and sold $29.4M; 45 added and 50 trimmed.

Schedule 13D and 13G filings on KROS

Owners of more than 5% must file within days, so these can be newer than the 13F data.

Questions about KROS ownership

Who owns KROS stock?
132 institutional investment managers reported KROS positions in their Form 13F filings for Q2 2026, holding 19,964,529 shares worth $214M in total. Nantahala Capital Management, LLC reported the largest position.
Are funds buying or selling KROS?
In Q2 2026, 15 managers opened new KROS positions, 45 added, 50 trimmed and 30 sold out. Managers that filed in both quarters added a net 1,377,909 shares.
How current is this KROS institutional ownership data?
It covers holdings as of the end of Q2 2026. Managers have 45 days after the quarter ends to file Form 13F (by August 14, 2026 for Q2 2026), so positions may have changed since.

From the SEC's Form 13F data sets for Q2 2026: every 13F holdings report, matched to KROS by CUSIP. Options are left out. KROS news and filings · KROS insider trades · Top funds